Marie‐Henriette Eerdekens

Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial

Annette Christoph, Marie‐Henriette Eerdekens, Maurits Kok et al. · Pain · 2017 · 97 citations · Full text

Nursing, Pharmacology, Pharmacotherapy +17

Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users

Karin Göhler, Marta Sokolowska, Kerri A. Schoedel et al. · Journal of Clinical Psychopharmacology · 2018 · 46 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cancer‐related chronic pain: Investigation of the novel analgesic drug candidate cebranopadol in a randomized, double‐blind, noninferiority trial

Marie‐Henriette Eerdekens, Sofia Kapanadze, E. Dietlind Koch et al. · European Journal of Pain · 2018 · 41 citations

Medicine, Pharmacology, Pharmacotherapy +17

Cebranopadol, a Novel First-in-Class Analgesic Drug Candidate: First Experience With Cancer-Related Pain for up to 26 Weeks

E. Dietlind Koch, Sofia Kapanadze, Marie‐Henriette Eerdekens et al. · Journal of Pain and Symptom Management · 2019 · 32 citations · Full text

Medicine, Oncology, Pharmacology +16

Direct conversion from tramadol to tapentadol prolonged release for moderate to severe, chronic malignant tumour‐related pain

Hans G. Kress, E. Dietlind Koch, Hristiyan Kosturski et al. · European Journal of Pain · 2016 · 16 citations · Full text

Nursing, Pharmacology, Pharmacotherapy +17